<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Hematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann. Hematol</journal-id>
      <journal-title-group>
        <journal-title>Annals of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0939-5555</issn>
      <issn pub-type="epub">1432-0584</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22130562</article-id>
      <article-id pub-id-type="pmc">3389251</article-id>
      <article-id pub-id-type="publisher-id">1379</article-id>
      <article-id pub-id-type="doi">10.1007/s00277-011-1379-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Neurolymphomatosis: role of positron emission tomography in diagnosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cheung</surname>
            <given-names>Carol</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lopes</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hung</surname>
            <given-names>Kwan-Ngai</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>Tao</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>Kwok-Wah</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kwong</surname>
            <given-names>Yok-Lam</given-names>
          </name>
          <address>
            <phone>+852-2-2555859</phone>
            <email>ylkwong@hkucc.hku.hk</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China </aff>
        <aff id="Aff2"><label>2</label>Department of Haematology, Hospital Conde S. Januario, Macau, China </aff>
        <aff id="Aff3"><label>3</label>Department of Surgery, Queen Mary Hospital, Hong Kong, China </aff>
        <aff id="Aff4"><label>4</label>Department of Diagnostic Radiology, Queen Mary Hospital, Hong Kong, China </aff>
        <aff id="Aff5"><label>5</label>Department of Pathology, Queen Mary Hospital, Hong Kong, China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>2</day>
        <month>12</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>2</day>
        <month>12</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2012</year>
      </pub-date>
      <volume>91</volume>
      <issue>8</issue>
      <fpage>1313</fpage>
      <lpage>1314</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>11</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>11</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2011</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2012</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>A 49-year-old woman presented with stage IA diffuse large B cell lymphoma (DLBCL) of the uterine cervix. She received four courses of R-CHOP (rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone) and two cycles of R-ICE (rituximab, ifosfamide, carboplatin, and etoposide), followed by local tomotherapy. A complete remission was achieved, as shown by 18F-fluorodeoxyglucose positron emission tomography&#x2013;computed tomography (PET/CT).</p>
    <p>However, she developed gradually numbness over her right thoracic 10 dermatome. A magnetic resonance imaging (MRI) scan performed 4&#xA0;months later showed abnormal signal intensity in the anterior and posterior wall of the lower thoracic cord, at the origin of cauda equina and at the anterior and posterior nerve roots of right thoracic 10 and thoracic 11 roots, suggestive of leptomeningeal deposits. Lumbar puncture showed normal cerebrospinal fluid, and although a dose of intrathecal methotrexate and cytarabine was given there was no symptomatic improvement.</p>
    <p>On referred 6&#xA0;months after the onset of neurologic symptoms, another MRI focusing on the thoracic spine showed abnormal signal intensity in the anterior and posterior wall of the lower thoracic cord at the origin of cauda equina and at the anterior and posterior right thoracic 10 and thoracic 11 nerve roots (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>, arrow). To resolve the nature of the lesion, a PET/CT scan was performed. It showed a hypermetabolic soft tissue nodule (standardized uptake value maximum, 4.2) extending across the right thoracic 10/11 neural foramen (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>, arrow), suggesting a lymphomatous lesion.<fig id="Fig1"><label>Fig. 1</label><caption><p>Imaging studies in neurolymphomatosis. <bold>a</bold> MRI scan showing a lesion (<italic>arrow</italic>) at the anterior and posterior right thoracic 10 and thoracic 11 nerve roots. <bold>b</bold> Positron emission tomography/computed tomography, showing an isolated hypermetabolic lesion in the right thoracic tenth foramen (<italic>arrow</italic>)</p></caption><graphic xlink:href="277_2011_1379_Fig1_HTML" id="MO1"/></fig></p>
    <p>The surgical resection specimen showed the presence of atypical lymphoid cells among the neuroganglion tissue, which were CD20+, CD3&#x2212;, and BCL-2+ (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a&#x2013;d</xref>). The overall features were consistent with DLBCL relapsing as neurolymphomatosis.<fig id="Fig2"><label>Fig. 2</label><caption><p>Histopathology of neurolymphomatosis. <bold>a</bold> Surgical specimen showing neuroganglion tissue diffusely infiltrated by abnormal lymphoid cells (hematoxylin&#x2013;eosin). <bold>b</bold> Lymphoid cells were positive for CD20 (immunoperoxidase stain). <bold>c</bold> Lymphoid cells were negative for CD3. <bold>d</bold> Lymphoid cells were positive for BCL-2</p></caption><graphic xlink:href="277_2011_1379_Fig2_HTML" id="MO2"/></fig></p>
    <p>Neurolymphomatosis refers to direct lymphomatous infiltration of the cranial and peripheral nerve and roots [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>]. It is a very rare condition, with a recent study identifying merely 50 patients from 12 centers in 5 countries over a 16-year period [<xref ref-type="bibr" rid="CR3">3</xref>]. Four different clinical presentations have been described: painful infiltration of nerves or roots; cranial neuropathy with or without pain; painless involvement of peripheral nerves; and painful or painless involvement of a single peripheral nerve [<xref ref-type="bibr" rid="CR1">1</xref>]. Aggressive B cell lymphoma is the predominant underlying pathology [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>]. Owing to the nonspecific presentation, the diagnosis is often delayed. Furthermore, biopsies are not feasible when deep-seated roots or cranial nerves are involved. Hence, when neurologic symptoms are the initial manifestation, the diagnosis of neurolymphomatosis may not be made until at post-mortem [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>]. In a patient with a history of lymphoma, the diagnostic challenge is to distinguish neurolymphomatosis from other pathologies not due to direct nerve invasion, including leptomeningeal lymphoma, nerve compression from adjacent lymphoma masses, neuropathy related to chemotherapy and radiotherapy, lymphoma-associated vasculitis, and paraneoplastic syndromes [<xref ref-type="bibr" rid="CR2">2</xref>]. Imaging studies are therefore very helpful in these differential diagnoses. Earlier studies have relied on MRI, which might not be able to distinguish between lymphomatous or a primary nervous tissue lesion. As shown in the present study, PET/CT allows the lesion to be accurately localized and gives an indication of the metabolic activity of the lesion [<xref ref-type="bibr" rid="CR4">4</xref>], which provides useful information on the differential diagnosis of the nature of the pathology.</p>
  </body>
  <back>
    <ack>
      <sec id="d29e319">
        <title>Open Access</title>
        <p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baehring</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Damek</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Betensky</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Hochberg</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
          <article-title>Neurolymphomatosis</article-title>
          <source>Neuro Oncol</source>
          <year>2003</year>
          <volume>5</volume>
          <fpage>104</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">12672282</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gan</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Azad</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cher</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab</article-title>
          <source>Neuro Oncol</source>
          <year>2010</year>
          <volume>12</volume>
          <fpage>212</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1093/neuonc/nop021</pub-id>
          <pub-id pub-id-type="pmid">20150388</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grisariu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Avni</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Batchelor</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Bent</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Bokstein</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Schiff</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kuittinen</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Chamberlain</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nemets</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shalom</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ben-Yehuda</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Siegal</surname>
              <given-names>T</given-names>
            </name>
            <collab>International Primary CNS Lymphoma Collaborative Group</collab>
          </person-group>
          <article-title>Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report</article-title>
          <source>Blood</source>
          <year>2010</year>
          <volume>115</volume>
          <fpage>5005</fpage>
          <lpage>5011</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2009-12-258210</pub-id>
          <pub-id pub-id-type="pmid">20368468</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosso</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Bruin</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Bent</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis of neurolymphomatosis with FDG PET</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>67</volume>
          <fpage>722</fpage>
          <lpage>723</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000230155.67464.37</pub-id>
          <pub-id pub-id-type="pmid">16924037</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
